• Home
  • Topics
    • Health Insurance Coverage
    • Medicare
    • Medicaid and CHIP
    • Blue Cross Blue Shield
    • Health Insurance Companies
    • Prescription Drugs and Pharmacy
    • Healthcare Policy and Law
    • Hospitals and Health Systems
    • Healthcare Business
    • Health Technology and AI
    • Senior Care
    • Public Health and Research
  • Guides
    • All Health Insurance Guides
    • Choosing a Health Insurance Plan
    • Individual Health Insurance
    • Family Health Insurance
    • High Deductible Health Plans
    • Short-Term Health Insurance
    • Self-Employed Health Insurance
    • Student Health Insurance
    • Low Income Health Insurance
    • Health Sharing Plans
  • Insurance Company List
  • About Us

Health Plan News

Timely Health Plan News and Commentary

Health Plan News
Home Hospitals and Health Systems Texas Children’s Hospital launches immunotherapy study

Texas Children’s Hospital launches immunotherapy study

Posted on August 28, 2014 Written by Editor

For children with food allergies, a trace amount of a substance can trigger deadly anaphylaxis within minutes of ingestion – the fear of which can be life altering for many families. To give hope to these patients and their families, researchers at Texas Children’s Hospital and Baylor College of Medicine are embarking on a landmark peanut immunotherapy trial, using a process known as desensitization where patients swallow tiny, increasing amounts of peanut over time. For more information about Texas Children’s Hospital’s Immunology, Allergy and Rheumatology Department, please visit http://texaschildrens.org/Locate/Departments-and-Services/Allergy-and-Immunology/.

The research team, led by Dr. Carla Davis, a specialist in the Pediatric Medicine, Immunology, Allergy and Rheumatology Department at Texas Children’s and assistant professor of pediatrics at Baylor, begin enrolling children with peanut allergies in the trial this month. The study will investigate the ability of peanut allergic children to take peanut flour, the mechanism by which the body develops tolerance, and measure the effect of viral infections. The goal of the trial is to find a standard of care that may lower the risk of severe allergic reactions in patients and eventually cease the allergy completely.

In Europe, a recent oral immunization trail (OIT) showed promise, and in the United States the Consortium for Food Allergy Research and Stanford University are both conducting similar studies. Presently, desensitization is not the standard of care and no study has determined the mechanism by which the body develops a tolerance. Davis and her team plan to monitor how the immunotherapy works and why, as well as develop systems to accurately identify patients who are good candidates for immunotherapy.

Related Coverage

  • Study Reveals Most Kids Hospitalized for Allergic Reactions Could Be Home in Two Hours
  • St. Jude Children’s Research Hospital Celebrates 50 Years
  • A Safer CAR-T Breakthrough? BioOra and Cincinnati Children’s Target Childhood Leukemia

For more reporting on this topic, see our Hospitals and Health Systems news hub.

Filed Under: Hospitals and Health Systems, Public Health and Research

Recent News

  • Paytient Survey: 61% of Insured Workers Paid Cash Without a Claim November 13, 2026
  • BCBS of Texas Drops Medicare Advantage Plans for 2027 November 10, 2026
  • How the 8 Biggest Health Insurers Are Reshaping 2027 Coverage November 10, 2026
  • One Insurer Controls Half the Market in 15 States, AMA Finds November 9, 2026
  • Cigna, UnitedHealthcare and Molina Exit ACA Markets for 2027 November 9, 2026
  • Health Insurer MLR Rebates Fall by More Than Half in 2026 November 9, 2026
  • IRS Raises 2027 FSA Limit to $3,500, HSA Limits to $4,500 November 9, 2026
  • ACA Sign-Ups Fall in 41 States as Net Premiums Jump 58% November 9, 2026
  • Medicaid Managed Care Now Covers 78% of Enrollees, Federal Data Shows November 9, 2026
  • Medicare Advantage Plans Shrink in 29 States for 2027 November 9, 2026

Search Our Site

Categories

  • Blue Cross Blue Shield
  • Health Insurance Companies
  • Health Insurance Coverage
  • Health Technology and AI
  • Healthcare Business
  • Healthcare Policy and Law
  • Hospitals and Health Systems
  • Medicaid and CHIP
  • Medicare
  • Prescription Drugs and Pharmacy
  • Public Health and Research
  • Senior Care

Entity Map

Disclaimer

All content on Health Plan News and information provided on this website is for informational purposes only and is not intended as a substitute for advice from your physician or other healthcare professional. You should not use the information on this site for diagnosis or treatment of any health problem or for prescription of any medication or other treatment. Always consult with a healthcare professional before starting any diet, exercise, or supplementation program, before taking any medication, or if you have or suspect you might have a health problem.

Copyright © 2026 - Privacy Policy - Terms of Use - Disclaimer